Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and stilbenes

raloxifene hydrochloride has been researched along with stilbenes in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (13.33)18.2507
2000's9 (60.00)29.6817
2010's3 (20.00)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Asplin, I; Baer, P; Brown, HR; Henke, B; Jones, SA; McDonnell, DP; Morris, DC; Norris, JD; Sauls, H; Wagner, BL; Willson, TM; Wolfe, S1
Christensen, DJ; Fowlkes, DM; McDonnell, DP; Nagel, SC; Norris, JD; Paige, LA; Wijayaratne, AL1
Galid, A; Kubista, E; Seifert, M1
Clegg, NJ; Scanlan, TS; Weatherman, RV1
Gapstur, S; Jordan, VC; Morrow, M1
Gajdos, C; Jordan, VC1
Candas, B; Couillard, S; Gutman, M; Labrie, C; Labrie, F; Roy, J1
Bentrem, D; Dardes, RC; De Los Reyes, A; Gajdos, C; Jordan, VC; O'Regan, RM; Robinson, SP1
Celik, O; Erdem, G; Hascalik, S; Karakas, HM; Tamser, M1
Celik, O; Hascalik, S; Mizrak, B; Tamser, M1
Cooperwood, JS; Khan, MO; Musa, MA1
Klinge, CM; Mattingly, KA1
Kim, HD; Ryu, JH; Song, YS; Yeo, HL1
Khazaei, M; Khazaei, MR; Mirzapur, P; Moradi, MT1
Bawankule, DU; Gupta, A; Imran Ahamad, M; John, AA; Khan, F; Luqman, S; Prakash, R; Singh, D; Wani, Z; Yadav, D1

Reviews

3 review(s) available for raloxifene hydrochloride and stilbenes

ArticleYear
Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
    Journal of the National Cancer Institute, 2001, Oct-03, Volume: 93, Issue:19

    Topics: Adult; Aged; Bone and Bones; Breast; Breast Neoplasms; Cardiovascular System; Cinnamates; Clinical Trials as Topic; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Female; Heart; Hot Flashes; Humans; Middle Aged; Models, Biological; Organ Specificity; Osteoporosis; Postmenopause; Premenopause; Prospective Studies; Protein Structure, Tertiary; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Estrogen; Risk; Risk Assessment; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Thrombophilia; Transcription, Genetic

2001
Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade.
    Clinical breast cancer, 2002, Volume: 2, Issue:4

    Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cinnamates; Drug Design; Forecasting; Humans; Molecular Biology; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Toremifene; Treatment Outcome

2002
Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
    Current medicinal chemistry, 2007, Volume: 14, Issue:11

    Topics: Breast Neoplasms; Drug Design; Estrogen Receptor alpha; Female; Humans; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Stilbenes; Structure-Activity Relationship; Tamoxifen; Thiophenes; Toremifene

2007

Other Studies

12 other study(ies) available for raloxifene hydrochloride and stilbenes

ArticleYear
Dissection of the molecular mechanism of action of GW5638, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in bone.
    Endocrinology, 1997, Volume: 138, Issue:9

    Topics: Animals; Bone and Bones; Bone Density; Cinnamates; Estradiol; Estrogen Antagonists; Estrogens; Female; Humans; Osteoporosis; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Stilbenes; Tamoxifen; Tumor Cells, Cultured; Uterus

1997
Comparative analyses of mechanistic differences among antiestrogens.
    Endocrinology, 1999, Volume: 140, Issue:12

    Topics: Blood Proteins; Breast Neoplasms; Cell Division; Cinnamates; Drug Stability; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Gene Expression; Humans; Protein Binding; Protein Conformation; Raloxifene Hydrochloride; Receptors, Estrogen; Stilbenes; Tamoxifen; Transcription, Genetic; Tumor Cells, Cultured

1999
The oestrogen receptor and its selective modulators in gynaecological oncology.
    European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 4

    Topics: Antineoplastic Agents, Hormonal; Cinnamates; Estrogen Antagonists; Female; Genital Neoplasms, Female; Humans; Norpregnenes; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Thiophenes; Toremifene

2000
Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.
    Chemistry & biology, 2001, Volume: 8, Issue:5

    Topics: Cinnamates; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Genes, Regulator; HeLa Cells; Humans; Protein Binding; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Transcription Factor AP-1; Transcription, Genetic

2001
Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.
    International journal of cancer, 2002, May-10, Volume: 99, Issue:2

    Topics: Animals; Breast Neoplasms; Cell Division; Cell Size; Cinnamates; Endometrium; Epithelial Cells; Estrogen Antagonists; Estrone; Female; Humans; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Stilbenes; Tamoxifen; Toremifene; Tumor Cells, Cultured

2002
Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:6

    Topics: Animals; Cinnamates; Endometrial Neoplasms; Estrogen Antagonists; Estrogens; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Raloxifene Hydrochloride; Receptors, Estrogen; Stilbenes; Tamoxifen; Transplantation, Heterologous; Tumor Cells, Cultured

2002
Magnetic resonance spectroscopic comparison of the effects of resveratrol (3,4',5-trihydroxy stilbene) to conjugated equine estrogen, tibolone and raloxifene on ovariectomized rat brains.
    European journal of obstetrics, gynecology, and reproductive biology, 2005, May-01, Volume: 120, Issue:1

    Topics: Animals; Aspartic Acid; Brain; Brain Chemistry; Choline; Creatine; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Magnetic Resonance Spectroscopy; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Resveratrol; Stilbenes

2005
Effects of resveratrol, raloxifene, tibolone and conjugated equine estrogen on vaginal squamous cell maturation of ovariectomized rats.
    Gynecologic and obstetric investigation, 2005, Volume: 60, Issue:4

    Topics: Animals; Epithelial Cells; Estrogens, Conjugated (USP); Female; Norpregnenes; Ovariectomy; Ovary; Papanicolaou Test; Raloxifene Hydrochloride; Rats; Rats, Wistar; Resveratrol; Stilbenes; Vagina; Vaginal Smears

2005
Diesel exhaust particulate extracts inhibit transcription of nuclear respiratory factor-1 and cell viability in human umbilical vein endothelial cells.
    Archives of toxicology, 2012, Volume: 86, Issue:4

    Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Drug Antagonism; Electron Transport Complex IV; Estradiol; Human Umbilical Vein Endothelial Cells; Humans; Mitochondria; Nuclear Respiratory Factor 1; Particulate Matter; Raloxifene Hydrochloride; Resveratrol; Stilbenes; Tamoxifen; Transcription, Genetic; Vehicle Emissions

2012
Design, synthesis, and biological evaluation of cyclopropyl analogues of stilbene with raloxifene side chain as subtype-selective ligands for estrogen receptor.
    Archives of pharmacal research, 2013, Volume: 36, Issue:9

    Topics: Animals; Binding, Competitive; Cell Line; Chlorocebus aethiops; Cyclopropanes; Drug Design; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Replacement Therapy; Estrogens; Genes, Reporter; Humans; Ligands; Molecular Structure; Raloxifene Hydrochloride; Recombinant Proteins; Response Elements; Selective Estrogen Receptor Modulators; Stereoisomerism; Stilbenes; Structure-Activity Relationship

2013
Apoptosis induction in human breast cancer cell lines by synergic effect of raloxifene and resveratrol through increasing proapoptotic genes.
    Life sciences, 2018, Jul-15, Volume: 205

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Caspases; Cell Line, Tumor; Cell Survival; Drug Synergism; Female; Humans; MCF-7 Cells; Nitric Oxide; Raloxifene Hydrochloride; Resveratrol; Selective Estrogen Receptor Modulators; Stilbenes

2018
Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents.
    Bioorganic & medicinal chemistry letters, 2020, 06-01, Volume: 30, Issue:11

    Topics: Amides; Animals; Binding Sites; Bone Morphogenetic Protein 2; Cell Differentiation; Cell Survival; Core Binding Factor Alpha 1 Subunit; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Osteoblasts; Osteogenesis; Raloxifene Hydrochloride; RNA, Messenger; Stilbenes

2020